A combination strategy of a semisynthetic macrolide, 5-O-mycaminosyltylonolide with polymyxin B nonapeptide for multi-drug resistance P. aeruginosa-Reference-Cited by-同舟云学术

A combination strategy of a semisynthetic macrolide, 5-O-mycaminosyltylonolide with polymyxin B nonapeptide for multi-drug resistance P. aeruginosa

Published:2023-05-19 Issue:8 Volume:76 Page:499-501
ISSN:0021-8820
Container-title:The Journal of Antibiotics
language:en
Short-container-title:J Antibiot

Author:

Kimishima Aoi,Sakai Kazunari,Honsho Masako,Matsui Hidehito^ORCID,Wasuwanich Paul,Watanabe Yoshihiro^ORCID,Iwatsuki Masato^ORCID,Sunazuka Toshiaki,Arima Naoaki,Abe Kazutoyo,Hanaki Hideaki,Asami Yukihiro^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology

Link

https://www.nature.com/articles/s41429-023-00628-9.pdf

Reference13 articles.

1. Antibiotic Resistance Threats in the United States. U.S. Department of Health and Human Services:CDC;2019. Available from: https://www.cdc.gov/drugresistance/Biggest-Threats.html.

2. Murray CJL, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.

3. Fischbach MA, Walsh CT, et al. Antibiotics for emerging pathogens. Science. 2009;325:1089–93.

4. Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543:15.

5. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Disco. 2007;6:29–40.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efflux pump inhibitor, phenylalanine-arginine beta-naphthylamide analog potentiates the activity of 5-O-mycaminosyltylonolide for multi-drug resistant Pseudomonas aeruginosa;The Journal of Antibiotics;2024-03-11

2. Overcoming Native Macrolide and Acquired Multidrug-Resistant <i>Pseudomonas aeruginosa</i> with Azithromycin and Polymyxin B Nonapeptide;BPB Reports;2023